Abstract:Background: Increasing evidence suggests copy number variations(CNVs) are series of crucial genetic change elements exerting vital impact in initiation and progression of malignancies, including colorectal cancer(CRC). LncRNAs are supposed as well-known regulating factors in driving or inhibiting human oncogenesis and may be responsible for prognostic evaluation. However, how to construct communications between these two factors underlying CRC is largely unknown. Methods: Here, we introduce diverse machine learnings for investigating prognostic-related copy number changes of lncRNAs. R package-iCluster is initially applied to reveal five prognostic subtypes from 289 cases of CRC by integrating messenger RNA expression levels, DNA methylation and DNA copy numbers. Differentially expressed lncRNAs(DE-lncRNAs) and protein-coding genes(DE-PCGs) across five subtypes are determined based on DESeq2, and WGCNA is furtherly exploited to chase modules closely associated with clinical phenotypes. Profiling frequency change involved with lncRNAs, we wonder whether deregulated lncRNAs are accompanied with copy differences, as well as exploration for lncRNAs tightly implicated with clinical outcome. Findings: There are originally 27 modules obtained according to WGCNA on the foundation of 4253 DE-lncRNAs and 5808 DE-PCGs among five subtypes, of which only 4 modules are contacting frequently with more than three kinds of clinical features, namely, tan, blue, yellow, magenta. Comparing lncRNAs expression patterns between copy-deleted or copy-amplified and the normal samples, we identify 9 lncRNAs(FAM87A, LOC101927752, KBTBD11-OT1, LOC100287015, LOC101929066, CASC11, HM13-AS1, ABALON, NKILA), the expression levels of these 9 lncRNAs are significantly guided by copy number deletions or amplifications. Besides, survival probabilities imply total 10 lncRNAs(LOC101927604, LOC105377267, CASC15, LINC-PINT, CLDN10-AS1, C14orf132, LMF1, LINC00675, CCDC144NL-AS1, LOC284454) conspicuously contribute to poor prognosis in CRC. Interpretation: In conclusion, our research is interested in copy number changes of lncRNAs, not only expending the spectrum of CNVs concerned with CRC, but also perfecting the regulation network of lncRNAs in CRC. The main purpose is to provide novel biomarkers for prognostic managements of CRC patients. Funding Statement: This study was supported by the Jiangsu Health and Health Committee (H2018074), the Nantong Science and Technology Program (MS22015055), the National Natural Science Foundation of China (81702086), the Overseas Returnee Start Package (2015) from the Jiangsu Provincial Department of Human Resources and Social Security, the 226 Talent Training Project of Nantong City (The Fifth Batch), and the Elite Doctor Program of the Affiliated Hospital of Nantong University. Declaration of Interests: All authors declare that they have no conflicts of interest. Ethics Approval Statement: Ethics approval not required - publicly available data.

CNV Primed lncRNAs Deregulation Contributes to Poor Prognosis in Colorectal Cancer

Copy Number Variations Primed Lncrnas Deregulation Contribute to Poor Prognosis in Colorectal Cancer

Identification of Necroptosis-Related Lncrnas for Prognosis Prediction and Screening of Potential Drugs in Patients with Colorectal Cancer

Genome-wide Transcriptomics and Copy Number Profiling Identify Patient-Specific CNV-lncRNA-mRNA Regulatory Triplets in Colorectal Cancer.

Identification of LncRNA Prognostic Biomarkers Associated with Copy Number Variants in Gastric Cancer

Identification of Prognostic Biomarkers of Hepatocellular Carcinoma Via Long Noncoding RNA Expression and Copy Number Alterations.

Exploring The Effect Of Differentially Expressed Long Non-Coding Rnas Driven By Copy Number Variation On Competing Endogenous Rna Network By Mining Lung Adenocarcinoma Data

Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data

Identification and Comprehensive Characterization of Lncrnas with Copy Number Variations and Their Driving Transcriptional Perturbed Subpathways Reveal Functional Significance for Cancer.

Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer

LncRNA profiles from Notch signaling: Implications for clinical management and tumor microenvironment of colorectal cancer

Prediction of Overall Survival for Colorectal Cancer: Establishment and Validation of a Prognostic Nomogram Based on a Competitive Endogenous RNAs Network Analysis

Identification of a 12-LncRNA long Lymph Node Metastasis Prognostic Signature for Cervical Cancer

Bioinformatic identification of genomic instability-associated lncRNAs signatures for improving the clinical outcome of cervical cancer by a prognostic model

Comprehensive Analyses of Correlation and Survival Reveal Informative Lncrna Prognostic Signatures in Colon Cancer.

Abstract 2414: Prognosis Prediction of Colorectal Cancer Using Gene Expression Profiles

Long Non-Coding RNAs As Prognostic Markers in Human Breast Cancer.

Prognostic relevance of DNA copy number changes in colorectal cancer.

Genome-wide Expression Profiling-Based Copy Number Variations and Colorectal Cancer Risk in Chinese

Comprehensive analysis of differentially expressed lncRNAs as diagnostic and prognostic markers for colorectal cancer

Long Noncoding Rna Profiles Identify Five Distinct Molecular Subtypes of Colorectal Cancer with Clinical Relevance